Cytotheryx has a strong team of experienced researchers focused on developing and advancing innovative technology and quality business leadership focused on addressing an unmet need. As visionaries dedicated to enabling medical breakthroughs for the individuals affected by liver disease and their loved ones, we are committed to providing the resources necessary for success. At Cytotheryx, we believe that transformative research and new therapies begin with a strong foundation.
Cytotheryx is committed to biomedical research focused on the development of a consistent, high-quality source of primary human hepatocytes and the application of those cells for multiple research and clinical applications.
Cytotheryx intends to become the foundational research company through which multiple clinical programs are advanced, including liver assist devices, cell therapy and ex vivo gene therapy.